A modest modification of daily dietary habits resulted in a visible change within the human body in only two months. Research ...

At a live Case-Based Roundtable event during the 2025 American Society of Hematology (ASH) annual meeting, Joshua Richter, MD, discussed the evolving role of selinexor (Xpovio) in ...

The addition of Zytiga (abiraterone) to Truqap (capivasertib) significantly prolonged radiographic progression-free survival ...

Entrada Therapeutics, Inc. (Nasdaq: TRDA) today reported financial results for the fourth quarter and full year ended December 31, 2025, and highlighted recent business updates. “We have started 2026 ...

DTNA outlined how its Gen 6 engine strategy stays focused on 2027 NOx compliance as GHG rules shift and regulatory clarity ...

Drinks high in iron-rich ingredients like spinach and pea protein can help improve energy levels, especially if you have low iron levels.

On track for INLIGHT clinical data update in 1Q 2026; fat loss similar to GLP-1 observed at three months and expected to ...

Rewriting the automotive rule book is no easy task. There’s a reason things have been done the same way for so long – if it ...

The OriGAMI-4 trial reveals subcutaneous Rybrevant's 45% response rate in metastatic head and neck cancer patients after ...

Two rivals, born into conflict and trading punches as they grow up, are thrust together as reluctant cohabitants by their parents’ marriage of convenience. And then the ultimate indignity, as they ...

By Hugo Francisco de Souza Can combining two gut hormone pathways unlock better obesity treatments? In the first human trial ...

Fourth quarter and full year 2025 total revenue of $192.6 million and $616.3 million, including BRIUMVI U.S. net revenue of $182.7 million and ...